253 related articles for article (PubMed ID: 8934120)
1. Radiological diagnosis of skeletal metastases.
Söderlund V
Eur Radiol; 1996; 6(5):587-95. PubMed ID: 8934120
[TBL] [Abstract][Full Text] [Related]
2. [Metastatic bone disease. Strategies for imaging].
Scutellari PN; Antinolfi G; Galeotti R; Giganti M
Minerva Med; 2003 Apr; 94(2):77-90. PubMed ID: 12858156
[TBL] [Abstract][Full Text] [Related]
3. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT.
Schmidt GP; Schoenberg SO; Schmid R; Stahl R; Tiling R; Becker CR; Reiser MF; Baur-Melnyk A
Eur Radiol; 2007 Apr; 17(4):939-49. PubMed ID: 16951929
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic imaging of bone metastases].
Scutellari PN; Addonisio G; Righi R; Giganti M
Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer.
Engelhard K; Hollenbach HP; Wohlfart K; von Imhoff E; Fellner FA
Eur Radiol; 2004 Jan; 14(1):99-105. PubMed ID: 12845463
[TBL] [Abstract][Full Text] [Related]
7. [Radiologic diagnosis of bone metastases].
Hansmann HJ; Wunsch C; Schneider B; Brado M; Flesch M; Richter GM; Kauffmann GW
Orthopade; 1998 Apr; 27(4):224-30. PubMed ID: 9616881
[TBL] [Abstract][Full Text] [Related]
8. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.
Gutzeit A; Doert A; Froehlich JM; Eckhardt BP; Meili A; Scherr P; Schmid DT; Graf N; von Weymarn CA; Willemse EM; Binkert CA
Skeletal Radiol; 2010 Apr; 39(4):333-43. PubMed ID: 20205350
[TBL] [Abstract][Full Text] [Related]
9. An integrated approach to the evaluation of metastatic bone disease.
Gold RI; Seeger LL; Bassett LW; Steckel RJ
Radiol Clin North Am; 1990 Mar; 28(2):471-83. PubMed ID: 2408106
[TBL] [Abstract][Full Text] [Related]
10. Whole-body MRI vs bone scintigraphy in the staging of Ewing sarcoma of bone: a 12-year single-institution review.
Kalus S; Saifuddin A
Eur Radiol; 2019 Oct; 29(10):5700-5708. PubMed ID: 30915559
[TBL] [Abstract][Full Text] [Related]
11. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.
Traill ZC; Talbot D; Golding S; Gleeson FV
Clin Radiol; 1999 Jul; 54(7):448-51. PubMed ID: 10437696
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of metastatic bone disease.
Traill Z; Richards MA; Moore NR
Clin Orthop Relat Res; 1995 Mar; (312):76-88. PubMed ID: 7634620
[TBL] [Abstract][Full Text] [Related]
14. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
15. The current role of radiography in the assessment of skeletal tumors and tumor-like lesions.
Priolo F; Cerase A
Eur J Radiol; 1998 May; 27 Suppl 1():S77-85. PubMed ID: 9652506
[TBL] [Abstract][Full Text] [Related]
16. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system.
Steinborn MM; Heuck AF; Tiling R; Bruegel M; Gauger L; Reiser MF
J Comput Assist Tomogr; 1999; 23(1):123-9. PubMed ID: 10050822
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
Lecouvet FE; Geukens D; Stainier A; Jamar F; Jamart J; d'Othée BJ; Therasse P; Vande Berg B; Tombal B
J Clin Oncol; 2007 Aug; 25(22):3281-7. PubMed ID: 17664475
[TBL] [Abstract][Full Text] [Related]
19. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
20. Comparison of whole-body MRI and skeletal scintigraphy for detection of bone metastatic tumors: a meta-analysis.
Wu Q; Yang R; Zhou F; Hu Y
Surg Oncol; 2013 Dec; 22(4):261-6. PubMed ID: 24210143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
